• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA ENVY TORIC HYDROPHOBIC ACRYLIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB ENVISTA ENVY TORIC HYDROPHOBIC ACRYLIC INTRAOCULAR LENS; LENS, MULTIFOCAL INTRAOCULAR Back to Search Results
Model Number ETN
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Hypopyon (1913); Toxic Anterior Segment Syndrome (TASS) (4469); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 06/26/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device remains implanted.A review of the lot device history record (dhr) did not identify any anomalies or nonconformities that could be related to this event.Based on the available information, the root cause of this event could not be determined.Bausch + lomb will continue to monitor for similar occurrences.
 
Event or Problem Description
It was reported that after implantation of an intraocular lens (iol) into the right eye (od), the patient presented with 4+ cell, fibrin, and hypopyon.The patient's best corrected visual acuity (bcva) did not decrease.Based on the findings the surgeon concluded the cause as toxic anterior segment syndrome (tass).In the surgeon's opinion, the most likely cause of the event is possible tass from the iol.The inflammation resolved after treatment, and patient outcome is good.Medications prescribed for use at home post-operatively: pred/moxi/brom 1%/0.5%/0.075% tid x 1 week, qd 3 weeks.Durezol every hour.Medrol po dose pack.
 
Additional Manufacturer Narrative
Additional info: b5, g3, h2, h11.
 
Event or Problem Description
Additional information was received indicating the tass event may have been caused by a cannula and unrelated to the lens.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVISTA ENVY TORIC HYDROPHOBIC ACRYLIC INTRAOCULAR LENS
Common Device Name
LENS, MULTIFOCAL INTRAOCULAR
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
Manufacturer (Section G)
BAUSCH + LOMB
21 north park place blvd.
clearwater FL 33759
Manufacturer Contact
shayan habibi
21 north park place blvd.
clearwater, FL 33759
7277246600
MDR Report Key22713598
Report Number0001313525-2025-00154
Device Sequence Number21313195
Product Code MFK
UDI-Device Identifier10757770644237
UDI-Public(01)10757770644237(17)271231(11)250130(10)3R02223
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P240005
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberETN
Device Catalogue NumberETNU425+180
Device Lot Number3R02223
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/07/2025
Supplement Date Received by Manufacturer08/05/2025
Initial Report FDA Received Date08/05/2025
Supplement Report FDA Received Date09/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/30/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALCON MONARCH IV, AMVISC
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexMale
-
-